One of the largest interventional cardiology companies in the world, Japan's Terumo Corp. , has built its business largely by dominating its home market and moving more cautiously beyond. That's true technologically as well as geographically: Terumo's business to date has been mostly cardiovascular, with a growing US and European business in devices for peripheral vascular disease. But with aspirations to become a truly global player, Terumo officials know they have to expand and round out their product line. The acquisition this month of Orange County, CA-based MicroVention Inc. is an important step in that direction, giving the Japanese giant a foothold in the one vascular business it doesn't have a significant stake in: interventional neuroradiology.
Founded nearly a decade ago, MicroVention has a novel microcoil technology used to treat cerebral aneurysms. Coated with its proprietary...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?